Shares of InMode Ltd. (NASDAQ:INMD - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $14.26 and traded as high as $15.17. InMode shares last traded at $15.10, with a volume of 425,021 shares trading hands.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. Barclays set a $19.00 price objective on shares of InMode and gave the company an "overweight" rating in a research report on Thursday, May 7th. Weiss Ratings restated a "sell (d+)" rating on shares of InMode in a report on Thursday, August 6th. Finally, Robert W. Baird dropped their target price on InMode from $17.00 to $14.00 and set a "neutral" rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, InMode presently has a consensus rating of "Hold" and an average target price of $16.00.
Check Out Our Latest Stock Report on InMode
InMode Price Performance
The company has a market capitalization of $867.96 million, a PE ratio of 12.28 and a beta of 1.89. The business's 50 day simple moving average is $14.86 and its 200 day simple moving average is $14.26.
InMode (NASDAQ:INMD - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The healthcare company reported $0.35 earnings per share for the quarter, meeting analysts' consensus estimates of $0.35. The business had revenue of $95.59 million during the quarter, compared to analysts' expectations of $94.89 million. InMode had a net margin of 20.69% and a return on equity of 11.99%. The business's revenue for the quarter was up .0% on a year-over-year basis. During the same period last year, the business earned $0.47 earnings per share.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the stock. Leonteq Securities AG purchased a new position in shares of InMode during the fourth quarter worth about $26,000. Quadrant Capital Group LLC raised its holdings in InMode by 127.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company's stock worth $29,000 after purchasing an additional 1,091 shares in the last quarter. Advisory Services Network LLC acquired a new stake in InMode in the third quarter valued at about $37,000. Basepoint Wealth LLC purchased a new stake in InMode in the 4th quarter valued at approximately $39,000. Finally, Deutsche Bank AG boosted its holdings in InMode by 35.9% in the 4th quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company's stock valued at $58,000 after purchasing an additional 1,037 shares in the last quarter. 68.04% of the stock is owned by hedge funds and other institutional investors.
About InMode
(
Get Free Report)
InMode Ltd. NASDAQ: INMD is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.
InMode's product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.
The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
